However, pneumonia/ARDS was present in only 3/10 (30%) subjects, whereas the remaining patients displayed mild or no respiratory symptoms, possibly suggesting a protective role of mucosal IgA against the progression toward severe symptomatology. This evidence concerns the gene CD79A and susceptibility to pneumonia measurement.